Walleye Trading’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.98M | Sell |
158,900
-1,200
| -0.7% | -$83.6K | 0.02% | 798 |
|
|
2025
Q4 | $10.6M | Buy |
160,100
+12,100
| +8% | +$782K | 0.02% | 895 |
|
|
2025
Q3 | $9.96M | Buy |
148,000
+80,600
| +120% | +$6.38M | 0.02% | 898 |
|
|
2025
Q2 | $5.88M | Sell |
67,400
-2,600
| -4% | -$204K | 0.01% | 1120 |
|
|
2025
Q1 | $4.78M | Buy |
70,000
+14,900
| +27% | +$1.22M | 0.01% | 1123 |
|
|
2024
Q4 | $4.29M | Buy |
55,100
+32,500
| +144% | +$2.41M | 0.01% | 1243 |
|
|
2024
Q3 | $1.52M | Sell |
22,600
-26,800
| -54% | -$2.2M | ﹤0.01% | 1854 |
|
|
2024
Q2 | $5.6M | Sell |
49,400
-45,100
| -48% | -$5.7M | 0.01% | 1004 |
|
|
2024
Q1 | $13.1M | Sell |
94,500
-14,600
| -13% | -$1.84M | 0.03% | 585 |
|
|
2023
Q4 | $13.5M | Buy |
109,100
+33,100
| +44% | +$3.38M | 0.03% | 616 |
|
|
2023
Q3 | $7.09M | Sell |
76,000
-167,700
| -69% | -$18.9M | 0.02% | 873 |
|
|
2023
Q2 | $31.3M | Sell |
243,700
-630,500
| -72% | -$76.3M | 0.09% | 193 |
|
|
2023
Q1 | $102M | Buy |
874,200
+211,800
| +32% | +$23.7M | 0.22% | 54 |
|
|
2022
Q4 | $75M | Buy |
662,400
+132,500
| +25% | +$14.5M | 0.21% | 60 |
|
|
2022
Q3 | $42.7M | Buy |
529,900
+124,600
| +31% | +$10.6M | 0.13% | 132 |
|
|
2022
Q2 | $30.2M | Buy |
405,300
+299,300
| +282% | +$27.3M | 0.1% | 197 |
|
|
2022
Q1 | $13.6M | Buy |
106,000
+16,000
| +18% | +$1.75M | 0.04% | 503 |
|
|
2021
Q4 | $12.1M | Buy |
90,000
+44,000
| +96% | +$6.32M | 0.04% | 501 |
|
|
2021
Q3 | $6.29M | Buy |
46,000
+2,400
| +6% | +$303K | 0.02% | 803 |
|
|
2021
Q2 | $4.65M | Buy |
43,600
+400
| +0.9% | +$38.4K | 0.02% | 842 |
|
|
2021
Q1 | $3.88M | Sell |
43,200
-259,200
| -86% | -$24.3M | 0.02% | 831 |
|
|
2020
Q4 | $28M | Buy |
302,400
+274,400
| +980% | +$24.5M | 0.12% | 109 |
|
|
2020
Q3 | $2.89M | Sell |
28,000
-3,600
| -11% | -$376K | 0.02% | 893 |
|
|
2020
Q2 | $3.2M | Buy |
31,600
+15,600
| +98% | +$1.4M | 0.02% | 779 |
|
|
2020
Q1 | $1.08M | Sell |
16,000
-5,200
| -25% | -$324K | 0.01% | 1249 |
|
|
2019
Q4 | $1.16M | Buy |
21,200
+3,200
| +18% | +$152K | 0.01% | 1668 |
|
|
2019
Q3 | $672K | Buy |
18,000
+2,400
| +15% | +$93.2K | 0.01% | 1905 |
|
|
2019
Q2 | $584K | Sell |
15,600
-68,000
| -81% | -$2.14M | 0.01% | 2075 |
|
|
2019
Q1 | $2.49M | Buy |
83,600
+61,600
| +280% | +$2.16M | 0.02% | 909 |
|
|
2018
Q4 | $659K | Sell |
22,000
-2,800
| -11% | -$88.8K | ﹤0.01% | 2198 |
|
|
2018
Q3 | $887K | Buy |
24,800
+16,000
| +182% | +$496K | ﹤0.01% | 2220 |
|
|
2018
Q2 | $209K | Sell |
8,800
-180,000
| -95% | -$3.82M | ﹤0.01% | 3607 |
|
|
2018
Q1 | $3.5M | Buy |
188,800
+62,800
| +50% | +$929K | 0.02% | 746 |
|
|
2017
Q4 | $1.81K | Sell |
126,000
-83,200
| -40% | -$1.08M | 0.01% | 1400 |
|
|
2017
Q3 | $2.56K | Buy |
209,200
+72,000
| +52% | +$1.27M | 0.01% | 1096 |
|
|
2017
Q2 | $2.51K | Buy |
137,200
+5,200
| +4% | +$96K | 0.02% | 1030 |
|
|
2017
Q1 | $2.79K | Buy |
132,000
+130,400
| +8,150% | +$2.55M | 0.02% | 845 |
|
|
2016
Q4 | $24K | Buy |
+1,600
| New | +$28.3K | ﹤0.01% | 4015 |
|
Other funds holding DXCM
VCM
VPM
Walleye Trading's DXCM Position: Q1 2026 in Review
Walleye Trading reduced its DexCom (DXCM) stake by 63% in Q1 2026, selling an estimated $8.02M and leaving 68,250 shares worth $4.29M. The position accounts for 0.01% of the portfolio, ranked #1224.
Walleye Trading first reported a position in DXCM in Q4 2015 and has held it in 23 quarters since. The position peaked at $12.2M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Walleye Trading held 68,250 shares of DexCom worth $4.29M as of Q1 2026.
- Walleye Trading sold 115,151 DexCom shares in Q1 2026, an estimated $8.02M.
- DexCom made up 0.01% of Walleye Trading's portfolio in Q1 2026, its #1224 holding.
- Walleye Trading first reported a position in DexCom in Q4 2015 and has held it in 23 quarters since.
- Walleye Trading's DexCom position peaked at $12.2M in Q4 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.